Ildong Holdings Co., Ltd. (KRX:000230)
7,300.00
+30.00 (0.41%)
At close: Jun 4, 2026
Ildong Holdings Revenue
Ildong Holdings had revenue of 148.88B KRW in the quarter ending March 31, 2026, with 5.53% growth. This brings the company's revenue in the last twelve months to 598.69B, down -3.22% year-over-year. In the year 2025, Ildong Holdings had annual revenue of 590.89B, down -6.90%.
Revenue (ttm)
598.69B
Revenue Growth
-3.22%
P/S Ratio
0.14
Revenue / Employee
8.32B
Employees
72
Market Cap
82.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 590.89B | -43.76B | -6.90% |
| Dec 31, 2024 | 634.65B | -3.79B | -0.59% |
| Dec 31, 2023 | 638.45B | -37.09B | -5.49% |
| Dec 31, 2022 | 675.54B | 83.17B | 14.04% |
| Dec 31, 2021 | 592.37B | -4.09B | -0.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jeil Pharma Holdings | 625.97B |
| HANDOK | 550.69B |
| Ilyang Pharmaceutical Co.,Ltd | 275.51B |
| Kyongbo Pharmaceutical | 269.64B |
| MYUNGMOON Pharm co.,Ltd | 197.37B |
| Kukje Pharma | 177.97B |
| CKD Bio | 159.93B |
| Yuyu Pharma | 143.52B |